Drug:
Reaction: NEUTROPENIA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26930988 |
AU |
3 | |
Neutropenia, |
||||
RIVAROXABAN, VINBLASTINE SULFATE, |
||||
| 102 | 26931010 |
69 | 2 | |
Enteritis, Neutropenia, |
||||
CARBOPLATIN, |
||||
| 103 | 26921529 |
CH |
24 | 1 |
Neutropenia, Drug interaction, |
||||
ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DOXORUBICIN, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, DIMENHYDRINATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARBOPLATIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AMPHOTERICIN B, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, URSODIOL, URSOSIOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 104 | 26921665 |
US |
58 | 2 |
Immune thrombocytopenia, Neutropenia, Diarrhoea, Therapy non-responder, |
||||
IRINOTECAN HYDROCHLORIDE, OXALIPLATIN, OXALIPLATIN, BEVACIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 105 | 26921835 |
EU |
74 | 1 |
Anaemia, Thrombocytopenia, Neutropenia, Neuropathy peripheral, Atrial fibrillation, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, |
||||
| 106 | 26921943 |
CA |
53 | |
Neutropenia, Treatment delayed, |
||||
TORIPALIMAB-TPZI, |
||||
| 107 | 26921965 |
2 | ||
Neutropenia, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 108 | 26921987 |
EU |
||
Bacterial infection, Cytokine release syndrome, Neutropenia, Secondary immunodeficiency, Infection, Thrombocytopenia, Febrile neutropenia, Anaemia, Off label use, |
||||
| 109 | 26922258 |
IN |
2 | |
Breast cancer metastatic, Malignant neoplasm progression, Neutropenia, Swelling, Pruritus, Product availability issue, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 110 | 26922374 |
EU |
81 | 2 |
Toxic epidermal necrolysis, Neutropenia, Syncope, Acute kidney injury, Rhabdomyolysis, Thrombocytopenia, Coma, Leukopenia, Hypokalaemia, Fall, Escherichia bacteraemia, Nausea, Stomatitis, Fatigue, Flushing, Decreased appetite, Weight decreased, Vomiting, Fatigue, General physical health deterioration, Hyponatraemia, Metabolic acidosis, Respiratory alkalosis, Hypotension, Anaemia, Asthenia, |
||||
CAPECITABINE, CAPECITABINE, ALPRAZOLAM, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, |
||||
| 111 | 26922380 |
EU |
61 | 1 |
Delayed graft function, Neutropenia, Tremor, Cytomegalovirus infection, |
||||
TACROLIMUS, TACROLIMUS, TACROLIMUS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, BASILIXIMAB, BASILIXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, |
||||
| 112 | 26922526 |
EU |
1 | |
Neutropenia, Pyelonephritis, Sepsis, |
||||
OCRELIZUMAB, |
||||
| 113 | 26922585 |
78 | 2 | |
Cholecystitis, Multiple organ dysfunction syndrome, Septic shock, Neutropenia, Product use in unapproved indication, |
||||
CARBOPLATIN, VINORELBINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 114 | 26922587 |
CH |
24 | 1 |
Neutropenia, Pyrexia, Respiratory syncytial virus infection, Rhinitis, Balanoposthitis, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARBOPLATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DIMENHYDRINATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, AMPHOTERICIN B, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, URSODIOL, URSOSIOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 115 | 26922604 |
EU |
1 | |
Neonatal hypoxia, Foetal heart rate disorder, Perinatal stroke, Thrombocytopenia, Neutropenia, |
||||
ACYCLOVIR, MISOPROSTOL, |
||||
| 116 | 26922825 |
CN |
||
Anaemia, Nausea, Fatigue, Leukopenia, Neutropenia, Constipation, Decreased appetite, Transaminases increased, Hypothyroidism, Pneumonitis, Hypophysitis, Myocarditis, Adrenal insufficiency, Type 1 diabetes mellitus, Neuropathy peripheral, Hyperplasia, Rash, |
||||
ATEZOLIZUMAB, PEMBROLIZUMAB, NIVOLUMAB, PENPULIMAB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CARBOPLATIN, |
||||
| 117 | 26922905 |
US |
55 | 1 |
Hypoglycaemia, Neutropenia, |
||||
VENETOCLAX, OBINUTUZUMAB, ERGOCALCIFEROL, |
||||
| 118 | 26923221 |
JP |
||
Leukopenia, Neutropenia, Febrile neutropenia, Thrombocytopenia, Anaemia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Hyponatraemia, Hyperkalaemia, Hypokalaemia, Blood creatinine increased, Hypoalbuminaemia, Decreased appetite, Nausea, Vomiting, Dysgeusia, Fatigue, Malaise, Rash, Constipation, Diarrhoea, |
||||
ATEZOLIZUMAB, CARBOPLATIN, ETOPOSIDE, |
||||
| 119 | 26923250 |
EU |
28 | 2 |
Neutropenia, |
||||
PREGABALIN, PREGABALIN, |
||||
| 120 | 26923668 |
CH |
68 | 2 |
COVID-19 pneumonia, Pneumonitis, Pneumonia, Electrocardiogram QT prolonged, Neutropenia, Alopecia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, EVEROLIMUS, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), EXEMESTANE, RIBOCICLIB, RIBOCICLIB, BEVACIZUMAB, IRBESARTAN, IBANDRONATE SODIUM, RANITIDINE, METHYLPREDNISOLONE, GUAIFENESIN AND CODEINE PHOSPHATE, |
||||
| 121 | 26923674 |
CH |
2 | |
Neutropenia, Exposure via breast milk, Neonatal respiratory distress syndrome, Bronchopulmonary dysplasia, Premature baby, Atrial septal defect, Foetal exposure during pregnancy, |
||||
OCRELIZUMAB, OCRELIZUMAB, |
||||
| 122 | 26923779 |
EU |
||
Neutropenia, Diarrhoea, Deep vein thrombosis, |
||||
LENALIDOMIDE, |
||||
| 123 | 26923856 |
RU |
2 | |
Infusion related reaction, Neutropenia, Herpes simplex, Bacteriuria, Leukocyturia, Respiratory tract infection viral, Thrombocytopenia, Urinary tract infection, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, |
||||
| 124 | 26923865 |
US |
52 | 2 |
Drug ineffective, Neurotoxicity, Myelosuppression, Neutropenia, |
||||
DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 125 | 26924746 |
EU |
2 | |
Neutropenia, Leukopenia, Thrombocytopenia, Oesophagitis, |
||||
DURVALUMAB, |
||||
| 126 | 26925143 |
US |
59 | 2 |
Full blood count decreased, Anaemia, Neutropenia, |
||||
LENALIDOMIDE, LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, EPINEPHRINE, ADRENALINUM, GABAPENTIN, HYDROCORTISONE SODIUM SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 127 | 26925254 |
US |
89 | 1 |
Anaemia, Red blood cell sedimentation rate increased, Oedema peripheral, Weight increased, Retinal vein occlusion, Osteopenia, Renal impairment, Stress fracture, Neutropenia, Sternal fracture, C-reactive protein increased, Uveitis, Rebound effect, Off label use, Vein rupture, Spinal fracture, Serum ferritin increased, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, AZACITIDINE, AZACITIDINE FOR, VORICONAZOLE, VORICONAZOLE INJECTION, ACYCLOVIR, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, |
||||
| 128 | 26925461 |
IN |
2 | |
Neutropenia, Off label use, |
||||
RIBOCICLIB, |
||||
| 129 | 26925513 |
AU |
73 | 1 |
Neutropenia, Klebsiella urinary tract infection, |
||||
LURBINECTEDIN, LURBINECTEDIN, LURBINECTEDIN, ATEZOLIZUMAB, |
||||
| 130 | 26925571 |
74 | 2 | |
Pancreatitis, Hypotension, Hypophagia, Acute hepatic failure, Decreased appetite, Neutropenia, Thrombocytopenia, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACYCLOVIR, |
||||
| 131 | 26925942 |
EU |
27 | 1 |
Neutropenia, Condition aggravated, |
||||
LANSOPRAZOLE, LANSOPRAZOLE, COLCHICINE, RIFAMPIN, RIFAMPIN, RIFAMPIN, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 132 | 26926332 |
EU |
67 | |
Thrombocytopenia, Neutropenia, Anaemia, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, HYDROXYUREA, |
||||
| 133 | 26926592 |
US |
84 | 2 |
Animal bite, Neutropenia, Infection, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 134 | 26928711 |
50 | 2 | |
Sepsis, Cellulitis, Thrombocytopenia, Neutropenia, Myelosuppression, Diarrhoea, Mental status changes, |
||||
NELARABINE, |
||||
| 135 | 26914977 |
AU |
78 | 2 |
Atrial fibrillation, Acute kidney injury, Acute hepatic failure, Acute myocardial infarction, Septic shock, Multiple organ dysfunction syndrome, Neutropenia, Cholecystitis, Gallbladder rupture, |
||||
CARBOPLATIN, VINORELBINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, |
||||
| 136 | 26914992 |
IN |
2 | |
Diabetes mellitus, Neutropenia, Musculoskeletal disorder, Asthenia, Vitamin D decreased, Vitamin B12 decreased, Glycosylated haemoglobin increased, Urinary tract infection, Off label use, Product dose omission issue, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 137 | 26915203 |
IN |
2 | |
Neutropenia, Off label use, |
||||
RIBOCICLIB, |
||||
| 138 | 26915340 |
VN |
2 | |
Neutropenia, Metastases to bone, Therapy partial responder, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, |
||||
| 139 | 26915630 |
EU |
54 | 2 |
Neutropenia, Suspected off label use, |
||||
HYDROCORTISONE SODIUM SUCCINATE, |
||||
| 140 | 26915636 |
EU |
1 | |
Neonatal hypoxia, Foetal heart rate disorder, Perinatal stroke, Neutropenia, Thrombocytopenia, |
||||
ACYCLOVIR, ACYCLOVIR, MISOPROSTOL, |
||||
| 141 | 26915637 |
EU |
70 | 2 |
Neutropenia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, DARATUMUMAB, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 142 | 26916153 |
OM |
51 | 2 |
Abdominal discomfort, Febrile neutropenia, Neutropenia, |
||||
POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, |
||||
| 143 | 26916175 |
KR |
69 | 2 |
Cellulitis gangrenous, Impaired healing, Administration site extravasation, Neutropenia, Infection, |
||||
DOXORUBICIN, VINBLASTINE SULFATE, DACARBAZINE, BRENTUXIMAB VEDOTIN, |
||||
| 144 | 26916587 |
JP |
74 | |
Thrombocytopenia, Neutropenia, |
||||
SACITUZUMAB GOVITECAN, PEGFILGRASTIM, AMLODIPINE BESYLATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, OXYCODONE HYDROCHLORIDE, |
||||
| 145 | 26916771 |
AU |
1 | |
Frontal lobe epilepsy, Schizophrenia, Neutropenia, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 146 | 26916783 |
EU |
61 | 2 |
Drug-induced liver injury, Neutropenia, Hypertransaminasaemia, |
||||
LETROZOLE, LETROZOLE TABLETS, ABEMACICLIB, |
||||
| 147 | 26916809 |
78 | 2 | |
Cholecystitis, Multiple organ dysfunction syndrome, Septic shock, Neutropenia, Product use in unapproved indication, |
||||
CARBOPLATIN, VINORELBINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 148 | 26916864 |
EU |
69 | 1 |
Neutropenia, Thrombocytopenia, Acute respiratory failure, Hypoxic-ischaemic encephalopathy, Haemoptysis, Asthenia, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, COLCHICINE, |
||||
| 149 | 26916900 |
EU |
2 | |
Neutropenia, Leukopenia, Thrombocytopenia, Alanine aminotransferase increased, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 150 | 26917003 |
GB |
81 | 1 |
Agranulocytosis, Neutropenia, Diarrhoea, |
||||
APIXABAN, BISOPROLOL FUMARATE, LANSOPRAZOLE, RAMIPRIL, SIMVASTATIN, AMLODIPINE, |
||||
| 151 | 26917037 |
US |
57 | 1 |
Cytokine release syndrome, Neutropenia, Lymphopenia, Off label use, |
||||
POLATUZUMAB VEDOTIN, MOSUNETUZUMAB, |
||||
| 152 | 26917054 |
EU |
77 | 2 |
Neutropenia, Agranulocytosis, |
||||
DASATINIB, BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 153 | 26917100 |
EU |
70 | 2 |
Neutropenia, Nausea, Asthenia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 154 | 26917201 |
GB |
81 | 1 |
Neutropenia, Agranulocytosis, Diarrhoea, |
||||
APIXABAN, BISOPROLOL FUMARATE, LANSOPRAZOLE, RAMIPRIL, SIMVASTATIN, AMLODIPINE, |
||||
| 155 | 26917417 |
US |
||
Death, Neuropathy peripheral, Cardiomyopathy, Cardiac failure, Leukopenia, Neutropenia, Thrombocytopenia, Atrial fibrillation, Lymphopenia, Anaemia, Off label use, |
||||
DARATUMUMAB, |
||||
| 156 | 26917552 |
US |
35 | 2 |
Neutropenia, Disease progression, Thrombocytopenia, Aspergillus infection, Central nervous system lesion, Drug resistance, |
||||
ISAVUCONAZONIUM SULFATE, VORICONAZOLE, VORICONAZOLE INJECTION, AMPHOTERICIN B, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SIROLIMUS, |
||||
| 157 | 26918052 |
CN |
44 | 2 |
Neutropenia, White blood cell count decreased, |
||||
ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 158 | 26918117 |
EU |
1 | |
Death, Neutropenia, Off label use, |
||||
OXALIPLATIN, DURVALUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, PREDNISONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, APREPITANT, APREPITANT, |
||||
| 159 | 26918146 |
EU |
69 | 1 |
Neutropenia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, |
||||
| 160 | 26918246 |
EU |
57 | 2 |
Thrombocytopenia, Rash maculo-papular, Neutropenia, |
||||
IVERMECTIN, LENALIDOMIDE, RITUXIMAB, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SIMVASTATIN, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 161 | 26918404 |
EU |
68 | 2 |
Myelosuppression, Neutropenia, |
||||
OLAPARIB, |
||||
| 162 | 26918710 |
AE |
||
Neutropenia, |
||||
RITLECITINIB, |
||||
| 163 | 26919160 |
66 | 2 | |
Neutropenia, Metastases to meninges, Anaemia, Alopecia, |
||||
| 164 | 26919464 |
EU |
1 | |
Neutropenia, Off label use, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, DURVALUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, PREDNISONE, PREDNISONE, OXALIPLATIN, APREPITANT, APREPITANT, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 165 | 26920229 |
JP |
2 | |
Neutropenia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 166 | 26920892 |
EU |
57 | 1 |
Hypothyroidism, Neutropenia, Neutropenia, Neutropenia, Anaemia, Anaemia, Anaemia, Anaemia, Oedema peripheral, Mucosal inflammation, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 167 | 26921175 |
26 | 1 | |
Peritonitis, Candida sepsis, Anaemia, Thrombocytopenia, Gamma-glutamyltransferase increased, Neutropenia, Blood alkaline phosphatase increased, Off label use, |
||||
CETUXIMAB, CETUXIMAB, CETUXIMAB, ENCORAFENIB, ENCORAFENIB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, DIMENHYDRINATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 168 | 26923703 |
36 | 2 | |
Neutropenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DARATUMUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULFATE, |
||||
| 169 | 26924313 |
62 | 2 | |
Neutropenia, |
||||
LENALIDOMIDE, |
||||
| 170 | 26909511 |
US |
2 | |
Neutropenia, Diarrhoea, |
||||
ABEMACICLIB, |
||||
| 171 | 26909531 |
JP |
8 | 2 |
Neutropenia, |
||||
PEGFILGRASTIM, SACITUZUMAB GOVITECAN, |
||||
| 172 | 26910185 |
EU |
5 | 2 |
Neutropenia, Neutropenia, Leukopenia, Leukopenia, Fatigue, Faeces soft, Gingival bleeding, Tachycardia, Dysuria, Dry skin, Fatigue, Carpal tunnel syndrome, Off label use, |
||||
RIBOCICLIB, EXEMESTANE, |
||||
| 173 | 26910199 |
JP |
7 | 2 |
Neutropenia, Rash, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 174 | 26910467 |
RU |
2 | |
Thrombocytopenia, Neutropenia, Hypogammaglobulinaemia, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, |
||||
| 175 | 26910575 |
EU |
35 | 2 |
Neutropenia, Hallucination, Immunosuppressant drug level increased, |
||||
TACROLIMUS, TACROLIMUS, TACROLIMUS, TACROLIMUS, TACROLIMUS, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, |
||||
| 176 | 26910606 |
EU |
69 | 1 |
Haemoptysis, Asthenia, Neutropenia, Thrombocytopenia, Acute respiratory failure, Hypoxic-ischaemic encephalopathy, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, COLCHICINE, |
||||
| 177 | 26910607 |
49 | 2 | |
Bone marrow failure, Pulmonary mass, Multiple organ dysfunction syndrome, Graft versus host disease, Delayed graft function, Candida infection, Cardiac valve vegetation, Herpes simplex encephalitis, Herpes simplex, Herpes simplex reactivation, Systemic candida, Neutropenia, Sepsis, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, ROMIPLOSTIM, |
||||
| 178 | 26910650 |
EU |
66 | 2 |
Pneumonia, Immune-mediated thyroiditis, Acute myocardial infarction, Neutropenia, Chronic obstructive pulmonary disease, |
||||
CARBOPLATIN, CARBOPLATIN, IPILIMUMAB, IPILIMUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 179 | 26910683 |
EU |
2 | |
Neutropenia, Alanine aminotransferase increased, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, |
||||
| 180 | 26910978 |
US |
35 | 2 |
Thrombocytopenia, Disease progression, Neutropenia, Aspergillus infection, Central nervous system lesion, Drug resistance, |
||||
AMPHOTERICIN B, VORICONAZOLE, VORICONAZOLE INJECTION, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SIROLIMUS, |
||||
| 181 | 26911002 |
52 | 2 | |
Drug ineffective, Neurotoxicity, Myelosuppression, Neutropenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MERCAPTOPURINE, CARBOPLATIN, TRASTUZUMAB, |
||||
| 182 | 26911055 |
US |
2 | |
Neutropenia, |
||||
RIBOCICLIB, |
||||
| 183 | 26911183 |
JP |
40 | 2 |
Neutropenia, Anaemia, |
||||
DOXORUBICIN, DOXORUBICIN, CISPLATIN, CISPLATIN, ETOPOSIDE, ETOPOSIDE, MITOTANE, MITOTANE, |
||||
| 184 | 26911270 |
EU |
66 | 1 |
Fungal infection, Condition aggravated, Cholecystitis acute, Neutropenia, Renal impairment, Blood bilirubin increased, Drug ineffective, |
||||
ISAVUCONAZONIUM SULFATE, AMPHOTERICIN B, GANCICLOVIR SODIUM, GANCICLOVIR, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, FENTANYL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, VASOPRESSIN, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 185 | 26911291 |
JP |
74 | 1 |
Leukopenia, Neutropenia, Neuropathy peripheral, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 186 | 26911296 |
JP |
76 | 2 |
Leukopenia, Neutropenia, Anaemia, Dysgeusia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 187 | 26911306 |
JP |
77 | 2 |
Leukopenia, Neutropenia, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 188 | 26911307 |
JP |
78 | 2 |
Leukopenia, Dysgeusia, Neutropenia, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 189 | 26911313 |
JP |
82 | 1 |
Leukopenia, Neutropenia, Neuropathy peripheral, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 190 | 26911340 |
EU |
81 | 1 |
Thrombocytopenia, Neutropenia, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, |
||||
| 191 | 26911605 |
EU |
27 | 2 |
Neutropenia, Hyperthyroidism, |
||||
CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEMBROLIZUMAB, |
||||
| 192 | 26911622 |
AE |
41 | 2 |
Gastrointestinal toxicity, Myelosuppression, Anal abscess, Neutropenia, Nausea, Diarrhoea, |
||||
PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, TRASTUZUMAB, CARBOPLATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 193 | 26912095 |
EU |
67 | 1 |
Neutropenia, Weight increased, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, BORTEZOMIB, BORTEZOMIB, BORTEZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, |
||||
| 194 | 26912463 |
VE |
2 | |
Neutropenia, Myelofibrosis, Pancytopenia, Loss of therapeutic response, |
||||
| 195 | 26912636 |
US |
56 | 2 |
Neutropenia, Drug eruption, |
||||
POMALIDOMIDE, |
||||
| 196 | 26912698 |
US |
6 | 1 |
Fusarium infection, Sinusitis fungal, Febrile neutropenia, Candida infection, Neutropenia, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, |
||||
| 197 | 26912846 |
IN |
2 | |
Neutropenia, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 198 | 26913939 |
EU |
18 | 2 |
Neutropenia, Hepatic cytolysis, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 199 | 26916656 |
79 | 1 | |
Pneumatosis intestinalis, Portal venous gas, Intestinal ischaemia, Aortic arteriosclerosis, Superior mesenteric artery syndrome, Neutropenia, Thrombocytopenia, Dyspnoea, Sepsis, Gastrointestinal necrosis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 200 | 26904628 |
EU |
21 | 2 |
Liver disorder, Alanine aminotransferase increased, Neutropenia, Leukopenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETOPOSIDE, ETOPOSIDE, DACARBAZINE, DACARBAZINE, PEGFILGRASTIM, PEGFILGRASTIM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
